AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34530254 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 201
Study 35958282 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone filling mesh container vertebroplasty
Number of subjects: 0
Study 35958282 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 0
Study 33653352 — intervention group
Group type: EXPERIMENTAL
Intervention: Dox@IR825@Gd@CDs
Number of subjects: 0
Study 33653352 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR laser irradiation with Dox@IR825@Gd@CDs
Number of subjects: 0
Study 33653352 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotarod test
Number of subjects: 0
Study 36383383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone group (intravenous and subsequent oral hydrocortisone, using a taper program)
Number of subjects: 436
Study 36383383 — intervention group
Group type: COMPARATOR
Intervention: No-hydrocortisone group
Number of subjects: 436
Study 36383383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone group
Number of subjects: 436
Study 34460948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg weekly subcutaneous)
Number of subjects: 60
Study 34460948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34460948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (after 48 weeks of treatment)
Number of subjects: 60
Study 34460948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (in patients with baseline IgE ≥ 200 IU/ml)
Number of subjects: 60
Study 34460948 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline IgE levels
Number of subjects: 60
Study 33316582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy
Number of subjects: 349
Study 33316582 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy
Number of subjects: 349
Study 32780023 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week electronic mindfulness-based intervention (eMBI)
Number of subjects: 68
Study 32780023 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 68
Study 34231846 — intervention group
Group type: EXPERIMENTAL
Intervention: DADEE intervention (9-week program with weekly sessions plus home-based tasks)
Number of subjects: 344
Study 34231846 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 344
Study 34370656 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoprotegerin and sclerostin levels in postmenopausal women with osteoporosis
Number of subjects: 40
Study 34370656 — intervention group
Group type: COMPARATOR
Intervention: Control group (postmenopausal women without osteoporosis)
Number of subjects: 40
Study 34370656 — intervention group
Group type: EXPERIMENTAL
Intervention: Other markers
Number of subjects: 40
Study 34370656 — intervention group
Group type: COMPARATOR
Intervention: Correlation with BMD
Number of subjects: 40
Study 32309876 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive indwelling of double-J stents (PI-DJS)
Number of subjects: 75
Study 32309876 — intervention group
Group type: COMPARATOR
Intervention: Preemptive indwelling of ureteral catheters (PI-UC)
Number of subjects: 75
Study 34537124 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block using 20-cc 0.5% bupivacaine solution
Number of subjects: 80
Study 34537124 — intervention group
Group type: COMPARATOR
Intervention: p-TAP (placebo) using 20-cc isotonic solution
Number of subjects: 80
Study 34537124 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 80
Study 34537124 — intervention group
Group type: COMPARATOR
Intervention: p-TAP (placebo)
Number of subjects: 80
Study 32487210 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 321
Study 32487210 — intervention group
Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 321
Study 35735195 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion imaging guidance (Vessel Navigator®, Philips)
Number of subjects: 64
Study 35735195 — intervention group
Group type: COMPARATOR
Intervention: Control (no fusion imaging guidance)
Number of subjects: 64
Study 34284344 — intervention group
Group type: EXPERIMENTAL
Intervention: DCVAC/LuCa and chemotherapy (carboplatin and paclitaxel)
Number of subjects: 112
Study 34284344 — intervention group
Group type: EXPERIMENTAL
Intervention: DCVAC/LuCa, chemotherapy, pegylated interferon‐?2b, and hydroxychloroquine
Number of subjects: 112
Study 34284344 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 112
Study 35984339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear appeal voice SMS intervention (once a week for 12 months)
Number of subjects: 324
Study 35984339 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 324
Study 32728771 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) lung cancer screening
Number of subjects: 543
Study 34090781 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerative cell therapy
Number of subjects: 150
Study 34343620 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga Skills Training (YST)
Number of subjects: 44
Study 34343620 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 44
Study 34071781 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training with vitamin D supplementation
Number of subjects: 45
Study 34071781 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D supplementation only
Number of subjects: 45
Study 34071781 — intervention group
Group type: COMPARATOR
Intervention: Aerobic interval training only
Number of subjects: 45
Study 35290454 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing for patients and caregivers (Arm 2)
Number of subjects: 510
Study 35290454 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing for patients (Arm 1)
Number of subjects: 510
Study 35290454 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Arm 3)
Number of subjects: 510
Study 33871851 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33871851 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32833128 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (150 min of moderate-intensity weekly exercise)
Number of subjects: 83
Study 35590284 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pivmecillinam (PIV) 400 mg QID for 1 week after 3 days of parenteral antibiotics
Number of subjects: 53
Study 34375336 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rotavirus vaccine
Number of subjects: 1525
Study 34375336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1525
Study 34375336 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS)
Number of subjects: 1525
Study 34375336 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement (MMS)
Number of subjects: 1525
Study 34375336 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-folic acid (IFA)
Number of subjects: 1525
Study 32917784 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg lanthanum carbonate thrice daily for 96 weeks
Number of subjects: 278
Study 32917784 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo thrice daily for 96 weeks
Number of subjects: 278
Study 35060860 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Learning Curriculum (ALC)
Number of subjects: 42
Study 35060860 — intervention group
Group type: COMPARATOR
Intervention: Passive Learning Cohort (PLC)
Number of subjects: 42
Study 35060860 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ALC and PLC post-test scores
Number of subjects: 42
Study 33622296 — intervention group
Group type: EXPERIMENTAL
Intervention: #10‐#15 Mechanical Glide Path super‐files with OGP motion (OGP 90°, 300 rpm)
Number of subjects: 30
Study 33622296 — intervention group
Group type: COMPARATOR
Intervention: #10‐#15 stainless steel K‐files manually
Number of subjects: 30
Study 32805050 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole apples
Number of subjects: 18
Study 32805050 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple puree
Number of subjects: 18
Study 32805050 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 18
Study 34923559 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 10 mg/kg
Number of subjects: 4623
Study 34923559 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 30 mg/kg
Number of subjects: 4623
Study 34923559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4623
Study 34923559 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 (both dosages)
Number of subjects: 4623
Study 32184305 — intervention group
Group type: EXPERIMENTAL
Intervention: WEE1 inhibitor adavosertib (AZD1775) in combination with cisplatin chemotherapy preoperatively (group A)
Number of subjects: 21
Study 32184305 — intervention group
Group type: EXPERIMENTAL
Intervention: WEE1 inhibitor adavosertib (AZD1775) in combination with postoperative cisplatin-based chemoradiation (group B)
Number of subjects: 21
Study 32184305 — intervention group
Group type: EXPERIMENTAL
Intervention: WEE1 inhibitor adavosertib (AZD1775) in combination with cisplatin chemotherapy (group A)
Number of subjects: 21
Study 33955686 — intervention group
Group type: EXPERIMENTAL
Intervention: GLPG1205 100 mg once daily for 12 days
Number of subjects: 14
Study 33955686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32438192 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA exposure
Number of subjects: 45
Study 34115162 — intervention group
Group type: EXPERIMENTAL
Intervention: Methenamine hippurate
Number of subjects: 92
Study 34115162 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 92
Study 33812492 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg per day) plus Mesalazine (2 g per day)
Number of subjects: 104
Study 33812492 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg per day) plus Mesalazine placebo
Number of subjects: 104
Study 33812492 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin placebo plus Mesalazine (2 g per day)
Number of subjects: 104
Study 33812492 — intervention group
Group type: COMPARATOR
Intervention: Aspirin placebo plus Mesalazine placebo
Number of subjects: 104
Study 33172883 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX/bevacizumab (MAVERICC)
Number of subjects: 648
Study 33172883 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI/bevacizumab (TRIBE)
Number of subjects: 648
Study 33172883 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI/bevacizumab (control cohorts)
Number of subjects: 648
Study 35732417 — intervention group
Group type: EXPERIMENTAL
Intervention: Shufeng Jiedu capsule (SFJDC) for 7 days
Number of subjects: 0
Study 35732417 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (Control)
Number of subjects: 0
Study 33279102 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 1600
Study 33279102 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 1600
Study 33790308 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir 3200 mg on day 1 followed by 600 mg twice daily from day 2 to day 10
Number of subjects: 100
Study 33790308 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine 800 mg on day 1 followed by 200 mg twice daily from day 2 to day 10, plus oral oseltamivir 75 mg/12 h/day for 10 days
Number of subjects: 100
Study 32319313 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-Assisted Activity (AAA) intervention
Number of subjects: 15
Study 32319313 — intervention group
Group type: COMPARATOR
Intervention: Control/usual ICU care
Number of subjects: 15
Study 36210622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mmol/L citrate
Number of subjects: 56
Study 36210622 — intervention group
Group type: COMPARATOR
Intervention: 3 mmol/L acetate
Number of subjects: 56
Study 33831342 — intervention group
Group type: EXPERIMENTAL
Intervention: Checkup Vision Assessment System
Number of subjects: 108
Study 33831342 — intervention group
Group type: COMPARATOR
Intervention: Standard VA reference tests
Number of subjects: 108
Study 35250032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ld-IL2 + MTX
Number of subjects: 40
Study 35250032 — intervention group
Group type: COMPARATOR
Intervention: Placebo + MTX
Number of subjects: 40
Study 32150758 — intervention group
Group type: EXPERIMENTAL
Intervention: TEE-guided strategy (edoxaban 60 mg once-daily or enoxaparin-warfarin)
Number of subjects: 2199
Study 32150758 — intervention group
Group type: COMPARATOR
Intervention: Non-TEE-guided strategy (edoxaban 60 mg once-daily or enoxaparin-warfarin)
Number of subjects: 2199
Study 34496669 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-driven medication therapy monitoring and management using a smartphone-enabled app
Number of subjects: 136
Study 34496669 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 136
Study 33497075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of corticosteroids (10 mg dexamethasone 1 hour before and 24 hours after surgery, placebo periarticular injection)
Number of subjects: 100
Study 33497075 — intervention group
Group type: COMPARATOR
Intervention: Periarticular injection of corticosteroids (40 mg triamcinolone acetonide during surgery, placebo intravenous administration)
Number of subjects: 100
Study 33497075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of corticosteroids
Number of subjects: 100
Study 33497075 — intervention group
Group type: COMPARATOR
Intervention: Periarticular injection of corticosteroids
Number of subjects: 100
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: I-PET after 4 cycles of R(R)-CHOP14
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: aaIPI
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low or low-intermediate aaIPI combined with ΔSUVmax > 70%
Number of subjects: 513
Study 34675112 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intermediate or high aaIPI combined with ΔSUVmax ≤ 70%
Number of subjects: 513
Study 34898155 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical stabilized cysteamine (st.Cys)
Number of subjects: 0
Study 33213185 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 403
Study 33213185 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics
Number of subjects: 403
Study 32006642 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively framed message
Number of subjects: 52
Study 32006642 — intervention group
Group type: COMPARATOR
Intervention: Positively framed message
Number of subjects: 52
Study 35913721 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure
Number of subjects: 40
Study 35913721 — intervention group
Group type: EXPERIMENTAL
Intervention: Paratracheal pressure
Number of subjects: 40
Study 35913721 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 40
Study 33012741 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence (AI) model trained on CAG videos
Number of subjects: 199
Study 33012741 — intervention group
Group type: EXPERIMENTAL
Intervention: AI model
Number of subjects: 199
Study 32176113 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional home‐based telerehabilitation group (ITG) using a wrist heart rate monitor, training at 70% to 80% of heart rate reserve for 60 minutes, 3 times a week for 12 weeks.
Number of subjects: 56
Study 32176113 — intervention group
Group type: COMPARATOR
Intervention: Regular outpatient training group (ROT), training at 70% to 80% of heart rate reserve for 60 minutes, 3 times a week for 12 weeks under direct supervision.
Number of subjects: 56
Study 32176113 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ITG and ROT)
Number of subjects: 56
Study 35598533 — intervention group
Group type: EXPERIMENTAL
Intervention: Epic sepsis prediction tool, education, and standardized order sets
Number of subjects: 6926
Study 35598533 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 6926
Study 32578325 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaced educational material
Number of subjects: 148
Study 35428213 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN)
Number of subjects: 864
Study 35428213 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Health Unit (MHU)
Number of subjects: 864
Study 35428213 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) and Mobile Health Unit (MHU)
Number of subjects: 864
Study 32100043 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate analgesics (medically prescribed or not)
Number of subjects: 8845
Study 32100043 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate analgesics (not medically prescribed)
Number of subjects: 8845
Study 32165156 — intervention group
Group type: EXPERIMENTAL
Intervention: BAL-directed CF therapy
Number of subjects: 141
Study 32165156 — intervention group
Group type: COMPARATOR
Intervention: Standard CF therapy
Number of subjects: 141
Study 35594613 — intervention group
Group type: EXPERIMENTAL
Intervention: 3rd line anti-EGFR therapy
Number of subjects: 1187
Study 35594613 — intervention group
Group type: COMPARATOR
Intervention: TRIBE patients
Number of subjects: 1187
Study 35594613 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment after 2nd progression
Number of subjects: 1187
Study 35594613 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment after 3rd progression
Number of subjects: 1187
Study 35594613 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment after 4th progression
Number of subjects: 1187
Study 35594613 — intervention group
Group type: EXPERIMENTAL
Intervention: RAS/BRAF wild-type patients
Number of subjects: 1187
Study 33006394 — intervention group
Group type: EXPERIMENTAL
Intervention: S5-methylation test
Number of subjects: 2661
Study 33006394 — intervention group
Group type: EXPERIMENTAL
Intervention: S5-methylation test (cut-point 3.1)
Number of subjects: 2661
Study 33006394 — intervention group
Group type: COMPARATOR
Intervention: HPV16/18
Number of subjects: 2661
Study 33006394 — intervention group
Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 2661
Study 33006394 — intervention group
Group type: COMPARATOR
Intervention: HPV16/18 plus cytology
Number of subjects: 2661
Study 32865375 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control (treatment with antiarrhythmic drugs or atrial fibrillation ablation)
Number of subjects: 2789
Study 32865375 — intervention group
Group type: COMPARATOR
Intervention: Usual care (limited rhythm control to management of atrial fibrillation-related symptoms)
Number of subjects: 2789
Study 32865375 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control
Number of subjects: 2789
Study 32865375 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2789
Study 35882513 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy (surgical management)
Number of subjects: 0
Study 35882513 — intervention group
Group type: COMPARATOR
Intervention: Medication (medical management)
Number of subjects: 0
Study 34349165 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathy triggering film sequence
Number of subjects: 46
Study 34349165 — intervention group
Group type: COMPARATOR
Intervention: Control film sequence
Number of subjects: 46
Study 36294153 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner support and initiating a planned quit attempt during treatment
Number of subjects: 327
Study 36294153 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline nicotine dependence and use of nicotine replacement
Number of subjects: 327
Study 36294153 — intervention group
Group type: EXPERIMENTAL
Intervention: More restrictive residential smoking rules and lower children's TSE at baseline
Number of subjects: 327
Study 35607441 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nursing based on zero-defect theory
Number of subjects: 174
Study 35607441 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative nursing care
Number of subjects: 174
Study 33958973 — intervention group
Group type: EXPERIMENTAL
Intervention: CD28 genetic variant CD28-rs3116494
Number of subjects: 3253
Study 33958973 — intervention group
Group type: EXPERIMENTAL
Intervention: CD80 genetic variant CD80-rs3850890
Number of subjects: 3253
Study 32869511 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth-friendly services (YFS)
Number of subjects: 200
Study 32869511 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth-friendly services plus a mobile phone application (YFS + APP)
Number of subjects: 200
Study 32869511 — intervention group
Group type: COMPARATOR
Intervention: Control group (YFS)
Number of subjects: 200
Study 33296222 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on CT images
Number of subjects: 40
Study 33296222 — intervention group
Group type: COMPARATOR
Intervention: Clinical factors model
Number of subjects: 40
Study 33296222 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics models (kNN, SVM, LR)
Number of subjects: 40
Study 33296222 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 40
Study 32256230 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative framework for asking clinical questions
Number of subjects: 100
Study 32256230 — intervention group
Group type: COMPARATOR
Intervention: PICO framework for asking clinical questions
Number of subjects: 100
Study 34699034 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD imaging system
Number of subjects: 40
Study 34699034 — intervention group
Group type: COMPARATOR
Intervention: 2D 4K imaging system
Number of subjects: 40
Study 33879131 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential below-elbow cast
Number of subjects: 560
Study 33879131 — intervention group
Group type: COMPARATOR
Intervention: Below-elbow plaster splint
Number of subjects: 560
Study 32772383 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/d)
Number of subjects: 152
Study 32772383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152